About Ming Fang
Ming Fang is a managing director, redmile group at Abcuro.
Form D filings also name Ming Fang as a director at Clear Labs and GRO Biosciences.
Ming Fang first appears on SEC filings in 2024.
Experience
This experience comes from Ming Fang's profile and from SEC filings. For roles taken from filings, the years are when the filings name Ming Fang in the role, so the role may have started earlier or lasted longer.
Abcuro, Inc. Current
Managing Director, Redmile Group
2023 – Present · Newton, MA
Develops immunotherapies for people with autoimmune diseases and cancer.
AT
Architect Therapeutics Current
Board Observer
2023 – Present
LT
Lycia Therapeutics Current
Board Director
2021 – Present
RG
Redmile Group Current
Managing Director
2015 – Present
AG
Agomab
Board Director
2023 – 2025
LI
LifeSprout, Inc.
Board Director
2020 – 2025
HB
Home Biosciences
Board Director
2021 – 2023
LV
LAVA Therapeutics N.V.
Board Observer
2020 – 2021
PH
Propeller Health
Board Observer
2014 – 2015
ME
Medivo
Board Observer
2014 – 2015
GG
Good Start Genetics
Board Observer
2014 – 2015
SI
Syapse Inc.
Board Observer
2014 – 2015
SA
Safeguard
Principal
2013 – 2015
ES
EscalaKid
Partner
2012 – 2013
MC
McKinsey & Company
Engagement Manager
2010 – 2013
ML
Merrill Lynch
Summer Associate
2008
SS
Sons of Stitches
Partner
2007 – 2008
GS
Gilead Sciences
Senior Manager
2005 – 2007
Key Colleagues at Startups
The people Ming Fang works with at each company, as listed on that company's latest Form D.
Abcuro, Inc. · Form D, Aug 13, 2026
JM
John Martin
Chief Executive Officer and director
Michael Dybbs
Partner, Samsara BioCapital and director
RH
Ron Hunt
Director
Mark Pruzanski
Chairman of the Board
Sarah Boyce
Director
Clear Labs, Inc. · Form D, Dec 30, 2024
GY
Greg Yap
Director
Gaurav Garg
Director
Mostafa Ronaghi
Director
SA
Sasan Amini
Executive officer and director
RK
Ramin Khaksar
Executive officer
EF
Edward Fan
Chief Financial Officer
GRO Biosciences Inc. · Form D, Jul 25, 2024
BB
Bruce Beutel
Director
DB
Dan Becker
Director
TL
Tracey Lodie
Executive officer
KB
Kevin Bitterman
Director
DM
Daniel Mandell
Chief Executive Officer and director
RD
Rakhshita Dhar
Director